PRF Technologies (PRFX) Total Current Liabilities (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Total Current Liabilities of $2.4 million in Q4 2025, down 0.61% on a QoQ basis from $2.5 million in Q2 2025, and little changed year-over-year from $2.4 million in Q4 2024.
PRF Technologies (PRFX) Total Current Liabilities (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Total Current Liabilities across 7 years of filings, most recently posting $2.4 million for Q4 2025.
- Quarterly Total Current Liabilities changed 0.04% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed 0.04% YoY) and the FY2025 annual result came in at $2.4 million, changed 0.04% from the prior year.
- Total Current Liabilities declined to $2.4 million in Q4 2025, from $2.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $4.9 million in Q2 2024 and troughed at $549000.0 in Q2 2022.
- A 5-year average of $1.5 million and a median of $1.1 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities sank 91.08% — and 2024, when it surged 346.26%.
- Tracing PRFX's Total Current Liabilities over 5 years: stood at $757000.0 in 2021, then jumped by 40.55% to $1.1 million in 2022, then slumped by 37.5% to $665000.0 in 2023, then jumped by 267.22% to $2.4 million in 2024, then fell by 0.04% to $2.4 million in 2025.
- Business Quant data shows PRFX's Total Current Liabilities at $2.4 million in Q4 2025, $2.5 million in Q2 2025, and $2.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 665,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 549,000.00 |
| Mar 31, 2022 | 768,000.00 |
| Dec 31, 2021 | 757,000.00 |
| Sep 30, 2021 | 628,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 741,000.00 |
| Dec 31, 2020 | 961,000.00 |
| Jun 30, 2020 | 6.87 Mn |
| Dec 31, 2019 | 6.34 Mn |